- $740.79m
- $775.34m
- $266.27m
- 69
- 21
- 47
- 43
Annual cashflow statement for Evolus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -163 | -46.8 | -74.4 | -61.7 | -50.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 62.5 | 19.3 | 20 | 28.4 | 33.7 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 35.6 | -11.5 | -34.3 | -5.89 | -6.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -57.9 | -33.4 | -84.9 | -34 | -18 |
| Capital Expenditures | -3.14 | -0.97 | -2.94 | -1.63 | -4.82 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | 15.3 | 5 | 0 | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 12.2 | 4.03 | -2.94 | -1.63 | -4.82 |
| Financing Cash Flow Items | -1.13 | 85.9 | -4.68 | -5.58 | 42.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 38.3 | 73.1 | -4.15 | 44.6 | 47.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.33 | 43.7 | -92.3 | 8.92 | 24.1 |